2015
DOI: 10.1016/j.mvr.2015.01.004
|View full text |Cite
|
Sign up to set email alerts
|

Decreased numbers of endothelial progenitor cells in patients in the early stages of systemic sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

3
17
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(20 citation statements)
references
References 34 publications
3
17
0
Order By: Relevance
“…28 CD34 þ cells are also decreased in rheumatoid arthritis, 29 systemic lupus erythematosus, 30 and systemic sclerosis, 31 all diseases with nailfold capillary abnormalities that are comparable to POAG. 32 Most notably, in systemic sclerosis, concomitant nailfold microvascular abnormalities (dilated capillaries and avascular zones) and reduced CD34 þ cells have been reported.…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…28 CD34 þ cells are also decreased in rheumatoid arthritis, 29 systemic lupus erythematosus, 30 and systemic sclerosis, 31 all diseases with nailfold capillary abnormalities that are comparable to POAG. 32 Most notably, in systemic sclerosis, concomitant nailfold microvascular abnormalities (dilated capillaries and avascular zones) and reduced CD34 þ cells have been reported.…”
Section: Discussionmentioning
confidence: 98%
“…32 Most notably, in systemic sclerosis, concomitant nailfold microvascular abnormalities (dilated capillaries and avascular zones) and reduced CD34 þ cells have been reported. 31,33 We hypothesize that a reduced number of these cells could lead to dilated capillaries and capillary dropout in vascular beds relevant to glaucoma. Figure 4.…”
Section: Discussionmentioning
confidence: 99%
“…Although the mechanisms underlying endothelial cell damage and defective repair remain incompletely understood, a large body of evidence suggests that a profound impairment of either neoangiogenesis or endothelial progenitor cell (EPC)-driven vasculogenesis is a key feature in SSc [ 6 10 ]. In fact, the dysregulation of multiple cellular and molecular pathways, that are required for post-ischemic endothelial cell and EPC compensatory responses, prevents peripheral vascular recovery [ 2 , 11 16 ].…”
Section: Introductionmentioning
confidence: 99%
“…Many review and articles have been published on this topic (Kahlenberg, 2011;Yamaguchi et al, 2010;Hill, 2003;Manetti, 2010;Blaise et al, 2014;Andrigueti et al, 2015). Here, we aimed to review the role of EPCs in rheumatic autoimmune diseases (ARDs), including systemic lupus erythematosus, vasculitis and rheumatoid arthritis.…”
Section: Introductionmentioning
confidence: 99%